Cargando…
Transiently Transfected Mammalian Cell Cultures: An Adaptable and Effective Platform for Virus-like Particle-Based Vaccines against Foot-and-Mouth Disease Virus
RNA viruses, such as foot-and-mouth disease virus (FMDV), have error-prone replication resulting in the continuous emergence of new viral strains capable of evading current vaccine coverage. Vaccine formulations must be regularly updated, which is both costly and technically challenging for many vac...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147724/ https://www.ncbi.nlm.nih.gov/pubmed/35632734 http://dx.doi.org/10.3390/v14050989 |
_version_ | 1784716878127562752 |
---|---|
author | Puckette, Michael Primavera, Victoria Martel, Erica Barrera, Jose Hurtle, William Clark, Benjamin Kamicker, Barbara Zurita, Mariceny Brake, David Neilan, John |
author_facet | Puckette, Michael Primavera, Victoria Martel, Erica Barrera, Jose Hurtle, William Clark, Benjamin Kamicker, Barbara Zurita, Mariceny Brake, David Neilan, John |
author_sort | Puckette, Michael |
collection | PubMed |
description | RNA viruses, such as foot-and-mouth disease virus (FMDV), have error-prone replication resulting in the continuous emergence of new viral strains capable of evading current vaccine coverage. Vaccine formulations must be regularly updated, which is both costly and technically challenging for many vaccine platforms. In this report, we describe a plasmid-based virus-like particle (VLP) production platform utilizing transiently transfected mammalian cell cultures that combines both the rapid response adaptability of nucleic-acid-based vaccines with the ability to produce intact capsid epitopes required for immunity. Formulated vaccines which employed this platform conferred complete protection from clinical foot-and-mouth disease in both swine and cattle. This novel platform can be quickly adapted to new viral strains and serotypes through targeted exchanges of only the FMDV capsid polypeptide nucleic acid sequences, from which processed structural capsid proteins are derived. This platform obviates the need for high biocontainment manufacturing facilities to produce inactivated whole-virus vaccines from infected mammalian cell cultures, which requires upstream expansion and downstream concentration of large quantities of live virulent viruses. |
format | Online Article Text |
id | pubmed-9147724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91477242022-05-29 Transiently Transfected Mammalian Cell Cultures: An Adaptable and Effective Platform for Virus-like Particle-Based Vaccines against Foot-and-Mouth Disease Virus Puckette, Michael Primavera, Victoria Martel, Erica Barrera, Jose Hurtle, William Clark, Benjamin Kamicker, Barbara Zurita, Mariceny Brake, David Neilan, John Viruses Article RNA viruses, such as foot-and-mouth disease virus (FMDV), have error-prone replication resulting in the continuous emergence of new viral strains capable of evading current vaccine coverage. Vaccine formulations must be regularly updated, which is both costly and technically challenging for many vaccine platforms. In this report, we describe a plasmid-based virus-like particle (VLP) production platform utilizing transiently transfected mammalian cell cultures that combines both the rapid response adaptability of nucleic-acid-based vaccines with the ability to produce intact capsid epitopes required for immunity. Formulated vaccines which employed this platform conferred complete protection from clinical foot-and-mouth disease in both swine and cattle. This novel platform can be quickly adapted to new viral strains and serotypes through targeted exchanges of only the FMDV capsid polypeptide nucleic acid sequences, from which processed structural capsid proteins are derived. This platform obviates the need for high biocontainment manufacturing facilities to produce inactivated whole-virus vaccines from infected mammalian cell cultures, which requires upstream expansion and downstream concentration of large quantities of live virulent viruses. MDPI 2022-05-07 /pmc/articles/PMC9147724/ /pubmed/35632734 http://dx.doi.org/10.3390/v14050989 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Puckette, Michael Primavera, Victoria Martel, Erica Barrera, Jose Hurtle, William Clark, Benjamin Kamicker, Barbara Zurita, Mariceny Brake, David Neilan, John Transiently Transfected Mammalian Cell Cultures: An Adaptable and Effective Platform for Virus-like Particle-Based Vaccines against Foot-and-Mouth Disease Virus |
title | Transiently Transfected Mammalian Cell Cultures: An Adaptable and Effective Platform for Virus-like Particle-Based Vaccines against Foot-and-Mouth Disease Virus |
title_full | Transiently Transfected Mammalian Cell Cultures: An Adaptable and Effective Platform for Virus-like Particle-Based Vaccines against Foot-and-Mouth Disease Virus |
title_fullStr | Transiently Transfected Mammalian Cell Cultures: An Adaptable and Effective Platform for Virus-like Particle-Based Vaccines against Foot-and-Mouth Disease Virus |
title_full_unstemmed | Transiently Transfected Mammalian Cell Cultures: An Adaptable and Effective Platform for Virus-like Particle-Based Vaccines against Foot-and-Mouth Disease Virus |
title_short | Transiently Transfected Mammalian Cell Cultures: An Adaptable and Effective Platform for Virus-like Particle-Based Vaccines against Foot-and-Mouth Disease Virus |
title_sort | transiently transfected mammalian cell cultures: an adaptable and effective platform for virus-like particle-based vaccines against foot-and-mouth disease virus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147724/ https://www.ncbi.nlm.nih.gov/pubmed/35632734 http://dx.doi.org/10.3390/v14050989 |
work_keys_str_mv | AT puckettemichael transientlytransfectedmammaliancellculturesanadaptableandeffectiveplatformforviruslikeparticlebasedvaccinesagainstfootandmouthdiseasevirus AT primaveravictoria transientlytransfectedmammaliancellculturesanadaptableandeffectiveplatformforviruslikeparticlebasedvaccinesagainstfootandmouthdiseasevirus AT martelerica transientlytransfectedmammaliancellculturesanadaptableandeffectiveplatformforviruslikeparticlebasedvaccinesagainstfootandmouthdiseasevirus AT barrerajose transientlytransfectedmammaliancellculturesanadaptableandeffectiveplatformforviruslikeparticlebasedvaccinesagainstfootandmouthdiseasevirus AT hurtlewilliam transientlytransfectedmammaliancellculturesanadaptableandeffectiveplatformforviruslikeparticlebasedvaccinesagainstfootandmouthdiseasevirus AT clarkbenjamin transientlytransfectedmammaliancellculturesanadaptableandeffectiveplatformforviruslikeparticlebasedvaccinesagainstfootandmouthdiseasevirus AT kamickerbarbara transientlytransfectedmammaliancellculturesanadaptableandeffectiveplatformforviruslikeparticlebasedvaccinesagainstfootandmouthdiseasevirus AT zuritamariceny transientlytransfectedmammaliancellculturesanadaptableandeffectiveplatformforviruslikeparticlebasedvaccinesagainstfootandmouthdiseasevirus AT brakedavid transientlytransfectedmammaliancellculturesanadaptableandeffectiveplatformforviruslikeparticlebasedvaccinesagainstfootandmouthdiseasevirus AT neilanjohn transientlytransfectedmammaliancellculturesanadaptableandeffectiveplatformforviruslikeparticlebasedvaccinesagainstfootandmouthdiseasevirus |